In recent months, several AI infrastructure companies have secured substantial seed funding, signaling a transformative shift in the health tech landscape.

This article delves into the business models of these companies, their potential applications in healthcare, the investors backing them, and their prospective impact on the industry.

1. EvolutionaryScale

Business Model: EvolutionaryScale leverages advanced AI algorithms to design novel proteins, aiming to revolutionize drug discovery and development. By utilizing generative AI, the company accelerates the identification of therapeutic candidates, potentially reducing the time and cost associated with bringing new drugs to market.

Healthcare Applications: In healthcare, EvolutionaryScale’s technology can be applied to create targeted therapies for various diseases, including rare and complex conditions. Their AI-driven approach allows for the rapid generation of protein structures that can be used in developing new medications, offering personalized treatment options and improving patient outcomes.

Investors: While specific investors in EvolutionaryScale’s recent funding round have not been publicly disclosed, the company’s innovative approach has attracted significant attention from venture capitalists focusing on biotech and AI.

Potential Impact on Health Tech: By streamlining the drug discovery process, EvolutionaryScale has the potential to disrupt traditional pharmaceutical development pipelines. Their AI-generated proteins could lead to breakthroughs in treating diseases that currently lack effective therapies, thereby transforming patient care and the pharmaceutical industry.

2. Physical Intelligence

Business Model: Physical Intelligence (PI) is pioneering the integration of advanced AI into robotics, aiming to enhance robots’ interaction with the physical world. The company focuses on training robots using extensive sensor and motion data to improve their dexterity and adaptability in various environments.

Healthcare Applications: In the healthcare sector, PI’s technology can be applied to develop assistive robots capable of performing complex tasks such as patient care, surgical assistance, and rehabilitation support. These robots could operate in dynamic clinical settings, providing support to healthcare professionals and improving patient outcomes.

Investors: PI recently raised $400 million, elevating its valuation to over $2 billion. While specific investors were not disclosed, the substantial funding reflects strong confidence in PI’s vision and technological capabilities.

Potential Impact on Health Tech: PI’s advancements in robotics could lead to significant improvements in healthcare delivery. By enabling robots to perform tasks with human-like adaptability, PI’s technology has the potential to alleviate workforce shortages, reduce human error, and enhance the efficiency of healthcare services.

3. WaveForms AI